Table 1 Clinical characteristics of the studied patients
From: Neuronal autoantibodies in a sample of Egyptian patients with drug-resistant epilepsy
| Â | N | % |
|---|---|---|
First presenting symptom | Â | Â |
 Refractory seizures | 19 | 76.00 |
 Psychiatric changes | 5 | 20.00 |
 Cognitive dysfunction | 3 | 12.00 |
 Movement disorder | 2 | 8.00 |
Seizure associations | ||
 None | 7 | 28.00 |
 Psychiatric | 12 | 48.00 |
 Cognitive | 8 | 32.00 |
 Movement disorder (tremor, dystonia) | 5 | 20.00 |
 Dysautonomia | 2 | 8.00 |
Seizure type | ||
 Focal motor onset | 5 | 20.00 |
 Focal non-motor onset (autonomic) | 1 | 4.00 |
 Focal with impaired awareness | 3 | 12.00 |
 Focal to bilateral tonic clonic | 11 | 44.00 |
 Generalized (tonic clonic/myoclonic) | 6 | 24.00 |
Frequency | ||
 Daily | 14 | 56.00 |
 Weekly | 5 | 20.00 |
 Status epilepticus (SE) | 4 | 16.00 |
 Refractory status epilepticus (RSE) | 2 | 8.00 |